{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:48:03Z","timestamp":1764053283053},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T00:00:00Z","timestamp":1332201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Whether the use of rifaximin for hepatic encephalopathy during liver transplant candidacy has an impact on post\u2010transplant infections is not known.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We compared the frequency and spectrum of infections within 90\u00a0d post\u2010transplant in liver transplant recipients who did and did not receive rifaximin for hepatic encephalopathy during transplant candidacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 110 consecutive liver transplant recipients, 30 (27%) received rifaximin. Rifaximin users were more severely ill based on higher <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>odel for <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>nd\u2010<jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>tage <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>iver <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>isease (<jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content>) score (p\u00a0=\u00a00.005). When controlled for <jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content> (stratified by <jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content>\u00a0&lt;\u00a030, <jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content>\u00a0\u2265\u00a030), the risk of infections was significantly lower in rifaximin vs. no rifaximin recipients (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\u00a0=\u00a00.269, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.078\u20130.0.934, p\u00a0=\u00a00.026). Rifaximin use was not associated with a higher risk of multidrug resistant bacterial infections (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\u00a0=\u00a01.8, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.42\u20138.35, p\u00a0=\u00a00.40). The probability of post\u2010transplant survival at 90\u00a0d did not differ for patients with or without rifaximin use (0.90 for both groups, p\u00a0=\u00a00.56).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Rifaximin appeared to have a protective effect against early post\u2010transplant infections in more severely ill liver transplant recipients. Rifaximin use did not select for multidrug resistant bacteria in these patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1399-0012.2012.01619.x","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T17:43:44Z","timestamp":1332438224000},"page":"849-852","source":"Crossref","is-referenced-by-count":14,"title":["Impact of rifaximin use for hepatic encephalopathy on the risk of early post\u2010transplant infections in liver transplant recipients"],"prefix":"10.1111","volume":"26","author":[{"given":"Hsin\u2010Yun","family":"Sun","sequence":"first","affiliation":[{"name":"Veterans Affairs Pittsburgh Healthcare System University Drive C Pittsburgh PA USA"},{"name":"Department of Internal Medicine National Taiwan University Hospital National Taiwan University College of Medicine Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Wagener","sequence":"additional","affiliation":[{"name":"Veterans Affairs Pittsburgh Healthcare System University Drive C Pittsburgh PA USA"},{"name":"University of Pittsburgh Pittsburgh PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas V.","family":"Cacciarelli","sequence":"additional","affiliation":[{"name":"Veterans Affairs Pittsburgh Healthcare System University Drive C Pittsburgh PA USA"},{"name":"University of Pittsburgh Pittsburgh PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Singh","sequence":"additional","affiliation":[{"name":"Veterans Affairs Pittsburgh Healthcare System University Drive C Pittsburgh PA USA"},{"name":"University of Pittsburgh Pittsburgh PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,20]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.3.2.201"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.05.019"},{"key":"e_1_2_5_4_1","first-page":"581","article-title":"[Double\u2010blind study of treatment with SF 68 or with antibiotics in acute enteritis in adults]","volume":"101","author":"Alvisi V","year":"1982","journal-title":"Clin Ter"},{"key":"e_1_2_5_5_1","first-page":"336","article-title":"Infectious diarrhea in the aged: controlled clinical trial of rifaximin","volume":"7","author":"Della Marchina M","year":"1988","journal-title":"Chemioterapia"},{"key":"e_1_2_5_6_1","first-page":"107","article-title":"Treatment of diarrhea in AIDS patients: double\u2010blind clinical trial","volume":"10","author":"Giacometti A","year":"1993","journal-title":"Farmaci&Terapia Int J Drugs Ther"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00348.x"},{"key":"e_1_2_5_8_1","first-page":"29","article-title":"Long\u2010term treatment with rifaximin and lactobacilli in post\u2010diverticulitic stenoses of the colon","volume":"15","author":"Giaccari S","year":"1993","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"e_1_2_5_9_1","first-page":"41","article-title":"Rifaximin: a new rifamycin for the prophylaxis of the septic complications in the large bowel surgery","volume":"94","author":"Scalco GB","year":"1987","journal-title":"Policlinico Sez Chir"},{"key":"e_1_2_5_10_1","first-page":"267","article-title":"Rifaximin effectiveness evaluation in the preparation of large intestine to surgery","volume":"8","author":"Verardi S","year":"1986","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(05)80681-2"},{"key":"e_1_2_5_12_1","first-page":"175","article-title":"Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double\u2010blind, randomized trial","volume":"23","author":"Pedretti G","year":"1991","journal-title":"Ital J Gastroenterol"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907893"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200104150-00016"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2001.21304"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00997.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-10-200505170-00005"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2008.20.2.186"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2012.01619.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2012.01619.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T02:21:03Z","timestamp":1698718863000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2012.01619.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,20]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1111\/j.1399-0012.2012.01619.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2012.01619.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,20]]}}}